Skip to content

Construction and Clinical Effect Study of an Individualized Variable Rate Feedback Infusion PCA Mode

Construction and Clinical Effect Study of an Individualized Variable Rate Feedback Infusion PCA Mode

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127253
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Interventions

Group A (Phase 2):Using a constant infusion mode of lipid in an analgesic pump
Group B (Phase 2):Using a variable rate feedback infusion mode analgesic pump
Group C (Phase 2):Use individualized rate regulation feedback infusion mode lipid analgesia pump
Model development cohort (Phase 1):None

Sponsors

Zhuhai People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >18 years; 2. ASA I-III level; 3. Women scheduled for elective laparoscopic hysterectomy; 4. Obtain written informed consent.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Individuals with mental illness or long-term use of psychotropic or sedative drugs; 3. History of chronic pain; 4. Serious cardiovascular or respiratory diseases; 5. Severe liver and kidney dysfunction (creatinine > 176umol/L, AST or ALT > 3 times the upper limit of the normal reference value); 6. History of opioid allergy; 7. Local anesthesia techniques such as nerve block are used for analgesia during or after surgery.

Design outcomes

Primary

MeasureTime frame
The dosage of sufentanil used within 48 hours after surgery;

Secondary

MeasureTime frame
Postoperative complications;The dosage of sufentanil used during each time period of 0-6h, 6-12h, 12-24h, 24-48h after surgery;Numerical Rating Scale(NRS);Incidence of adverse events within 48 hours postoperatively.;

Countries

China

Contacts

Public ContactHongliang Liu

Zhuhai People's Hospital

liuhl75@163.com+86 23 65075688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026